netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Search
 Formulary Chapter 6: Endocrine system - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
06.01 Drugs used in diabetes (0,0)
06.01.01 Insulins (0,0)
06.01.01.01 Short-acting insulins (8,9)
06.01.01.02 Intermediate- and long-acting insulins (9,5)
spacespace Biphasic insulins (4,3)
06.01.01.03 Hypodermic equipment (17,1)
06.01.02 Antidiabetic drugs (0,0)
06.01.02.01 Sulphonyureas (2,5)
06.01.02.02 Biguanides (2,0)
06.01.02.03 Other antidiabetic drugs (0,16)
spacespace Alpha glucosidase inhibitors (0,1)
spacespace DPP4 inhibitors (gliptins) (3,0)
spacespace GLP1 agonists (6,1)
spacespace Meglitinides (1,0)
spacespace SGL2 inhibitors (5,0)
spacespace Thiazolidinediones (1,0)
06.01.03 Diabetic ketoacidosis (0,0)
06.01.04 Treatment of hypoglycaemia (3,0)
spacespace Chronic hypoglycaemia (1,0)
06.01.05 Treatment of diabetic nephropathy and neuropathy (0,0)
06.01.06 Diagnostic and monitoring agents for diabetes mellitus (0,0)
spacespace Blood glucose and blood ketone monitoring (3,1)
spacespace Urinalysis (3,0)
spacespace Oral glucose tolerance test (1,1)
06.02 Thyroid and Antithyroid drugs (0,0)
06.02.01 Thyroid hormones (3,1)
06.02.02 Antithyroid drugs (3,1)
06.03 Corticosteroids (0,0)
06.03.01 Replacement therapy (1,0)
06.03.02 Glucocorticoid therapy (10,1)
spacespace Disadvantages of corticosteroids (0,0)
spacespace Use of corticosteroids (0,0)
spacespace Pregnancy and breastfeeding (0,0)
spacespace Administration (0,0)
spacespace Withdrawal of corticosteroids (0,0)
06.04 Sex hormones (0,0)
06.04.01 Female sex hormones and their modulators (1,0)
06.04.01.01 Oestrogens and HRT (17,1)
spacespace Ethinylestradiol (1,0)
spacespace Raloxifene (1,0)
spacespace Oestrogen only tablets (0,0)
06.04.01.02 Progestogens (5,1)
06.04.02 Male sex hormones and antagonists (2,0)
spacespace Anti-androgens (2,0)
06.04.03 Anabolic steroids (0,0)
06.05 Hypothalamic and pituitary hormones and anti-oestrogens (0,0)
06.05.01 Hypothalamic and anterior pituitary hormones and anti-oestrogens (0,0)
spacespace Anti-oestrogens (1,0)
spacespace Anterior pituitary hormones (7,1)
spacespace Hypothalmic hormones (2,0)
06.05.02 Posterior pituitary hormones and antagonists (0,0)
spacespace Posterior pituitary hormones (6,0)
spacespace Antidiuretic hormone antagonists (2,1)
06.06 Drugs affecting bone metabolism (0,0)
spacespace Osteoporosis (0,0)
06.06.01 Calcitonin and parathyroid hormone (1,1)
06.06.02 Bisphosphonates and other drugs affecting bone metabolism (0,0)
spacespace Bisphosphonates (8,0)
spacespace Denosumab (2,0)
spacespace Strontium renelate (1,0)
06.07 Other endocrine drugs (0,0)
06.07.01 Bromocriptine and other dopaminergic drugs (3,0)
06.07.02 Drugs affecting gonadotrophins (0,0)
spacespace Gonadorelin analogues (6,1)
spacespace Breast pain (mastalgia) (0,0)
06.07.03 Metyrapone (1,0)
06.07.04 Somatomedins (0,0)
netFormulary